POINT MUTATIONS AND ALLELIC LOSS IN THE TP53 LOCUS OF CUTANEOUS MALIGNANT MELANOMAS

被引：9
|
作者：
WEISS, J [1 ]
CAVENEE, WK [1 ]
HERBST, RA [1 ]
JUNG, EG [1 ]
ARDEN, KC [1 ]
机构：
[1] LUDWIG INST CANC RES,SAN DIEGO BRANCH,SAN DIEGO,CA 92093
来源：
ARCHIVES OF DERMATOLOGICAL RESEARCH | 1994年 / 286卷 / 07期
关键词：
TP53; LOCUS; CUTANEOUS MALIGNANT MELANOMA; POINT MUTATIONS; ALLELIC LOSS;
D O I：
10.1007/BF00371803
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：417 / 419
页数：3
相关论文
共 50 条
  • [31] TP53 and mutations in human cancer
    Szymanska, K
    Hainaut, P
    ACTA BIOCHIMICA POLONICA, 2003, 50 (01) : 231 - 238
  • [32] TP53 mutations sensitize to decitabine
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2017, 14 : 72 - 72
  • [33] Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
    Li, Xuerui
    Chen, Xiaoqing
    Wen, Lingzhu
    Wang, Yulei
    Chen, Bo
    Xue, Yunlian
    Guo, Liping
    Liao, Ning
    THORACIC CANCER, 2020, 11 (07) : 1861 - 1868
  • [34] Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissues
    Wertz, IE
    Deitch, AD
    Gumerlock, PH
    GandourEdwards, R
    Chi, SG
    White, RWDV
    HUMAN PATHOLOGY, 1996, 27 (06) : 573 - 580
  • [35] LSC-2017-KRAS & TP53 mutations cause malignant mesothelioma
    Krontira, Anthi
    Marazioti, Antonia
    Vreka, Malamati
    Iliopoulou, Marianthi
    Lilis, Ioannis
    Giotopoulou, Georgia
    Spella, Magda
    Petrou, Helen
    Stathopoulos, Georgios
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [36] TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer
    Ralf Erber
    Christian Conradt
    Nils Homann
    Christel Enders
    Martin Finckh
    Andreas Dietz
    Hagen Weidauer
    Franz X Bosch
    Oncogene, 1998, 16 : 1671 - 1679
  • [37] TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer
    Erber, R
    Conradt, C
    Homann, N
    Enders, C
    Finckh, M
    Dietz, A
    Weidauer, H
    Bosch, FX
    ONCOGENE, 1998, 16 (13) : 1671 - 1679
  • [38] Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
    A Langerød
    TI Andersen
    I Bukholm
    A-L Børresen Dale
    Breast Cancer Research, 2 (Suppl 1)
  • [39] Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas
    Semczuk, A
    Marzec, B
    Skomra, D
    Roessner, A
    Cybulski, M
    Rechberger, T
    Schneider-Stock, R
    ONCOLOGY, 2005, 69 (04) : 317 - 325
  • [40] TP53 gene mutations in canine osteosarcoma
    Kirpensteijn, Jolle
    Kik, Marja
    Teske, Erik
    Rutteman, Gerard R.
    VETERINARY SURGERY, 2008, 37 (05) : 454 - 460
12345